Disc Medicine, Inc.
IRON
Rank in Stocks
#4957
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a... Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Share Price
$75.39
Last synced: 2026-10-22
Market Cap
$2.89B
Change (1 day)
-0.80%
Change (1 year)
-9.92%
Country
US
Trade Disc Medicine, Inc. (IRON)
Category
Healthcare
Revenue for Disc Medicine, Inc. (IRON)
Revenue in Jun 2026 TTM: 0.00
According to Disc Medicine, Inc. latest financial reports the company's current revenue (TTM) is 0.00. In 2024 the company made a revenue of 0.00 equal to the revenue in the year 2023 that was 0.00. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Disc Medicine, Inc. from 2020 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | 0.00% |
| 2025 | 0.00 | 0.00% |
| 2024 | 0.00 | 0.00% |
| 2023 | 0.00 | 0.00% |
| 2022 | 0.00 | 0.00% |
| 2021 | 0.00 | 0.00% |
| 2020 | 0.00 | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $12.62B | - |
US
|
|
| $2.23B | - |
US
|
|
| $15.74B | - |
AU
|
|
| $9.57B | - |
BE
|
|
| $6.02B | - |
NL
|
